Genetic susceptibility to breast cancer in French-Canadians: Role of carcinogen-metabolizing enzymes and gene-environment interactions

International Journal of Cancer

Volumn 92, Issue 2, 2001, Pages 220-225

  Krajinovic, M ^a   Ghadirian, P ^a   Richer, C ^a   Sinnett, H ^b   Gandini, S ^a   Perret, C ^b   Lacroix, A ^c   Labuda, D ^c   Sinnett, D ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Breast cancer; Cytochrome P 450; Genetic polymorphism; Genotype; Glutathione S transferase; N acetyltransferase; Xenobiotic metabolism

Indexed keywords

ACYLTRANSFERASE; CARCINOGEN; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2D6; GLUTATHIONE TRANSFERASE;

ACETYLATOR PHENOTYPE; ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANADA; CANCER RISK; CONTROLLED STUDY; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

ARYLAMINE N-ACETYLTRANSFERASE; BREAST NEOPLASMS; CANADA; CARCINOGENS; CARCINOMA; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2D6; ENVIRONMENTAL EXPOSURE; FEMALE; FRANCE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MENOPAUSE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0035871980     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1184>3.0.CO;2-H     Document Type: Article

References (59)

1. Breast cancer
2. Socio-demographic characteristics, smoking, medical and family history, and breast cancer
3. Breast cancer risk and nutrient intake among French Canadians in Montreal: A case-control study
4. Risk factors for breast cancer development
5. Transformation of human breast epithelial cells by chemical carcinogens
6. Nutritional risk factors for breast cancer
7. Chemically induced mammary gland cancer in the National Toxicology Program's carcinogenesis bioassay
8. Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods
9. Cancer risk of heterocyclic amines in cooked foods: An analysis and implications for research
10. Carcinogenicity of aromatic hydrocarbons directly applied to rat mammary gland
11. DNA adducts in human breast tissue: Association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes
12. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology
13. Kinetics of arylamine N-acetyltransferase in tissues from human breast cancer
14. N-Acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland
15. Interindividual variation in the metabolic activation of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells
16. Expression of cytochromes P450 in human breast tissue and tumors
17. Genetic predisposition to lung cancer
18. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis
19. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism
20. Les arylamine N-acétyltransferases: Génétique à la susceptibilité aux xénobiotiques
21. Molecular mechanism of genetic polymorphism of drug metabolism
22. Relationship between genotype and function of the human CYP1A1 gene
23. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans
24. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
25. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk
26. Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility
27. A prospective study of NAT2 acetylation geno-type, cigarette smoking, and risk of breast cancer
28. A C4887A polymorphism in exon 7 of human CYP1A1: Population frequency, mutation linkages, and impact on lung cancer susceptibility
29. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk
30. Glutathione S-transferase class mu deletion polymorphism and breast cancer: Results from prevalent versus incident cases
31. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk
32. N-Acetyltransferase 1 genetic polymorphism, cigarette smoking, well-done meat intake, and breast cancer risk
33. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer
34. Breast cancer risk, meat consumption and N-acetyl-transferase (NAT2) genetic polymorphisms
35. Well-done meat intake and the risk of breast cancer
36. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study
37. Rapid detection of CYP1AI, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay
38. Susceptibility to childhood acute lymphoblastic leukemia: Influence of CYP1A1, CYP2D6, GSTM1 and GSTT1 genetic polymorphisms
39. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer
40. Study of the frequencies of CYP1A1 gene polymorphisms and glutathione S-transferase mul gene in primary breast cancers: An update with an additional 114 cases
41. Genetics of CYP1A1: Coamplification of specific alleles by polymerase chain reaction and association with breast cancer
42. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women
43. A systematic review of genetic polymorphisms and breast cancer risk
44. Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphisms: Evidence of a lack of association in Caucasians and African Americans
45. Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility
46. Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk
47. Molecular mechanisms of estrogen carcinogenesis
48. CYP1A1 mutations 4887A, 4889G, 5639C and 6235C in the Polish population and their allelic linkage, determined by peptide nucleic acid-mediated PCR clamping
49. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer
50. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer
51. Increased frequency of wild-type arylamine-Nacetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer
52. Cigarette smoking, N-acetyltransferase 1 and 2 and breast cancer risk
53. Molecular genetics of the N-acetyltransferases
54. N-Acetyltransferase 2 genotypes, meat intake and breast cancer risk
55. Relationship between NAT1 genotype and phenotype in a Japanese population
56. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder
57. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: Evidence of a gene-gene-exposure three-way interaction
58. Identification and characterization of variant alleles of human acetyltransferase natl with defective function using p-aminosalicylate as an in-vivo and in-vitro probe
59. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT1)